SCHEMBL6169639

SCHEMBL6169639

CCC1(c2ccc(Oc3ccccc3)cc2)NC(=S)N(c2ccccc2)C1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 1/20 0.47
CYP2C19 P33261 3/20 0.46
TSHR P16473 1/20 0.46
ELANE P08246 2/20 0.41
MMP2 P08253 3/20 0.41
MMP3 P08254 3/20 0.41
MMP8 P22894 3/20 0.41
MMP14 P50281 1/20 0.41
MMP17 Q9ULZ9 1/20 0.41
LMNA P02545 2/20 0.41
MGLL Q99685 1/20 0.40
MMP9 P14780 2/20 0.40
MMP13 P45452 2/20 0.40
PSMB5 P28074 1/20 0.38
GRK5 P34947 1/20 0.38
TYRO3 Q06418 1/20 0.38
DYRK1B Q9Y463 1/20 0.38
NTRK1 P04629 1/20 0.37
IGF1R P08069 1/20 0.37
FGFR1 P11362 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6167711 0.81 CNR1 (0.50) CNR1TSHRMMP2MMP3MMP8
SCHEMBL6169740 0.80 CNR1 (0.69) CNR1MMP2MMP3MMP8LMNA
SCHEMBL6167893 0.76 ELANE (0.45) CNR1TSHRELANEMMP2MMP3
SCHEMBL6168712 0.75 CNR1 (0.46) CNR1MMP2MMP3MMP8MGLL
SCHEMBL6168870 0.75 GAA (0.46) CNR1MMP2MMP3MMP8LMNA
SCHEMBL6169738 0.74 CNR1 (0.43) CNR1MMP2MMP3MMP8LMNA
SCHEMBL6167462 0.71 CNR1 (0.41) CNR1TSHRMMP2MMP3MMP8
SCHEMBL6168079 0.71 LMNA (0.47) CNR1MMP2MMP3MMP8LMNA
SCHEMBL6168455 0.71 PGR (0.41) CNR1TSHRMMP2MMP3MMP8
SCHEMBL7481341 0.67 CNR1 (0.55) CNR1TSHRELANELMNAGRK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1546111-A2 2-THIOHYDANTOINE DERIVATIVE COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF DIABETES LABORATOIRES FOURNIER S.A. (FR) 2005-06-29 EP disclosed
WO-2004031160-A2 2-THIOHYDANTOINE DERIVATIVE COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF DIABETES LABORATOIRES FOURNIER S.A. (FR) 2004-04-15 WO disclosed